Location History:
- 52 Uppsala, SE (1996)
- Upsala, SE (1995 - 1997)
- Uppsala, SE (1993 - 2002)
Company Filing History:
7 out of 120 
1 out of 832,880 Years Active: 1993-2002
Title: The Innovative Mind of Bo F Oberg
Introduction
Bo F Oberg, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of pharmaceuticals through his innovative research and patent developments. With a total of seven patents to his name, Oberg's work is primarily focused on substances that exhibit anti-retroviral activity, crucial in the fight against viral infections.
Latest Patents
Oberg's latest patents include groundbreaking work on the anti-retroviral activity of 2′,3′-dideoxy-3′-fluoronucleosides. His research has led to the development of derivatives of purine and a range of antivirally active compounds that have substantial implications for treating various viral infections, including AIDS. These compounds are characterized by a complex formula (I) featuring various amino, hydroxy, and halogen substitutions, alongside detailed processes for their preparation, pharmaceutical compositions, and methods for the treatment of virus infections.
Career Highlights
As a prominent figure at Medivir AB, Oberg has carved out a reputable career in the pharmaceutical industry, focusing on the development of medications fighting retroviral diseases. His work not only emphasizes the creation of new antiviral compounds but also enhances existing treatments by discovering novel mechanisms of action and applications.
Collaborations
Throughout his career, Bo F Oberg has collaborated with esteemed colleagues, including Karl N Johansson and Roelf Datema. These partnerships have facilitated the sharing of ideas and expertise, furthering innovation in antiviral research and leading to the successful development of effective pharmaceutical solutions.
Conclusion
Bo F Oberg's inventive spirit and dedication to his work have positioned him as an influential figure in pharmaceutical innovation. With his continued research and commitment to advancing anti-retroviral therapies, Oberg’s contributions stand to significantly impact public health and the treatment of viral infections worldwide.